Pharmaceuticals & Drugs
CONCORDBIO
Concord Biotech Ltd.
Caution — weak structure
Setup readiness
Late Stage
- Pivot Levels
- ₹1231.7-1414.9
- Support Level
- ₹1312.7
- Resistance
- ₹1689.5
- Risk Distance
- 7.2% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Weak structure
Stage 3 trend context — relative strength and breakout quality remain primary constraints.
Bullish factors
- MACD below zero — weak trend (−2).
- Relative strength remains below leadership thresholds.
- Still materially below prior highs, which limits momentum quality.
- Trend stage reads as Stage 3 — not in a classic Stage 2 advance.
- 1 prior pivot rejection in last 60d (-8 pts).
- ATR 4.0%/day — healthy volatility (+4).
- Pivot type: flat-top — premium structure.
- RSI 54 — ideal setup zone.
- Price has built a constructive advance from the 52-week low.
- Distribution pressure visible across recent sessions.
- Pocket pivot detected, but broader structure still shows distribution pressure.
- Recent volume expansion — institutional participation may be returning.
- Volume flow suggests quiet institutional accumulation.
Risk factors
- Heavy overhead supply (62%) — trapped sellers above
- Not in a Stage 2 uptrend (Stage 3)
Overall view
Localized accumulation signals (such as a pocket pivot) are present, but broader volume flow still reflects distribution pressure. Overall setup quality remains limited despite any localized compression or accumulation cues.
Setup research
CONCORDBIO — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Positives
Building toward the pivot (9% below)
- Volume drying up into the base — supply fading
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 3 — caution
- Sector Mid-pack (#20/40)
- Relative strength Lagging (RS 42)
- Trend strength Strong (ADX 29)
Negatives
This idea is wrong below ₹1312.7 (-2.1% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹1312.7
- Pivot — failure re-entry below₹1407.9
Risk distance
Risk ≈ ₹102.23/share from entry ₹1414.9.
Reasons to skip 2
Disqualifiers that apply even if the score looks good.
- Heavy overhead supply (62%) — trapped sellers above
- Not in a Stage 2 uptrend (Stage 3)
Setup metrics Latest scan
CONCORDBIO Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest research scan.
Structure
Momentum
Risk
More scanner fields
CONCORDBIO Support & Resistance Levels
Research chart
Daily price action with pivot, support, and resistance levels from our latest scan, plus relative strength vs Nifty.
Pivot levels, support and resistance are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Seasonality — monthly returns
How this stock moved month by month over the last ~2 years.
A rough tendency, not a reliable pattern. Research only, not advice.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Pattern highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
CONCORDBIO FAQ Common swing-trading questions
Frequently asked questions about CONCORDBIO
What are the screener observations for CONCORDBIO?
On Swing Edge's swing-setup framework, Concord Biotech Ltd. (CONCORDBIO) currently grades C — mixed — needs patience. Building toward the pivot (9% below). Flagged today. This is educational research, not investment advice.
What are CONCORDBIO's support and resistance levels?
For CONCORDBIO, near-term support sits around ₹1,312.7 (the base/stop zone); overhead resistance is around ₹1,407.9 (the breakout pivot); the next resistance above is ₹1,689.5. This is educational research, not investment advice.
What is the breakout / pivot level for CONCORDBIO?
The breakout pivot for CONCORDBIO is around ₹1,407.9. Price is about 8.7% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is CONCORDBIO above its 50-day and 200-day moving averages?
CONCORDBIO is currently in Stage 3, not a confirmed Stage 2 uptrend, so trend support from the key moving averages is weaker than ideal for a swing entry. This is educational research, not investment advice.
How strong is CONCORDBIO versus the market (RS rank)?
CONCORDBIO has a relative strength (RS) rank of 42 out of 100 versus the NSE universe, making it lagging the broader market on relative strength. Trend strength (ADX) reads 29, indicating a strong trend. This is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-25 — not live intraday NSE quotes.